Lynne Marie Sullivan - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Lynne Marie Sullivan has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $175.
Profile
Lynne Marie Sullivan is a corporate insider at Solid Biosciences Inc. (SLDB). Sullivan has also held reporting roles at Inozyme Pharma, Inc. (INZY) and Unity Biotechnology, Inc. (UBX). Sullivan has reported 3 insider filings with the SEC since 2024. The most recent filing was in June 2026.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Solid Biosciences Inc.
- Inozyme Pharma, Inc.
- Unity Biotechnology, Inc.
Awards & honors
- CFO at Unity Biotechnology
- CFO at Inozyme Pharma
Trading Pattern
InsiderAlpha's records for Lynne Marie Sullivan go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. 1 recorded transaction carries a Rule 10b5-1 flag, meaning it was pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Lynne Marie Sullivan has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at Solid Biosciences Inc. (SLDB) - 1 filing, 2026
- Insider at Inozyme Pharma, Inc. (INZY) - 1 filing, 2025
- CFO & Head of Corp. Dev. at Unity Biotechnology, Inc. (UBX) - 1 filing, 2024
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-11-06 | UBX | Unity Biotechnology, Inc. | S - Open-market sale [10b5-1] | 136 | $1.29 | $175 |
Companies - Last 90 Days
- Solid Biosciences Inc. (SLDB) - 1 filing, last 2026-06-11
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Lynne Marie Sullivan has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Alexander Cumbo - $984K of SLDB open-market activity in the last 12 months
- David T. Howton - $434K of SLDB open-market activity in the last 12 months
- Kevin Tan - $330K of SLDB open-market activity in the last 12 months
- Jessie Hanrahan - $297K of SLDB open-market activity in the last 12 months
- Gabriel Brooks - $281K of SLDB open-market activity in the last 12 months
- Paul Herzich - $274K of SLDB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Lynrock Lake LP
- Lynx1 Capital Management LP
- MA Eagle Holdings Fund
- Magnetar Financial LLC
- Meyer Malka
- John C. Malone
- Paul B. Manning
- Manufacturers Life Insurance Co (Bermuda Branch)
Frequently Asked Questions
Who is Lynne Marie Sullivan?
Lynne Marie Sullivan is a corporate insider at Solid Biosciences Inc. (SLDB). Sullivan has also held reporting roles at Inozyme Pharma, Inc. (INZY) and Unity Biotechnology, Inc. (UBX). Sullivan has reported 3 insider filings with the SEC since 2024. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Lynne Marie Sullivan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Lynne Marie Sullivan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($175) across all tracked filings.
Where can I see all of Lynne Marie Sullivan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Lynne Marie Sullivan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.